Brief: Microba Life Sciences Posts A$4.81 Mln Q4 Fy24 Unaudited Revenue
25/07/2024 03:45
July 25 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* A$4.81M IN Q4 FY24 UNAUDITED REVENUE, UP 20.2% QOQ
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million